Published in FEBS Lett on February 20, 2008
Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07
Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell (2012) 5.92
Differential network biology. Mol Syst Biol (2012) 3.74
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech (2011) 2.97
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther (2013) 2.64
Cancer systems biology: a network modeling perspective. Carcinogenesis (2009) 2.22
Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science (2015) 1.95
Quantitative phosphoproteomics by mass spectrometry: past, present, and future. Proteomics (2008) 1.50
Blueprint for antimicrobial hit discovery targeting metabolic networks. Proc Natl Acad Sci U S A (2010) 1.42
Systems biology and the future of medicine. Wiley Interdiscip Rev Syst Biol Med (2011) 1.38
Navigating cancer network attractors for tumor-specific therapy. Nat Biotechnol (2012) 1.18
Distinct patterns of DNA damage response and apoptosis correlate with Jak/Stat and PI3kinase response profiles in human acute myelogenous leukemia. PLoS One (2010) 1.08
RasGRP Ras guanine nucleotide exchange factors in cancer. Front Biol (Beijing) (2013) 1.04
Deciphering post-translational modification codes. FEBS Lett (2013) 0.99
Traditional chinese medicine-based network pharmacology could lead to new multicompound drug discovery. Evid Based Complement Alternat Med (2012) 0.98
Evolution: a guide to perturb protein function and networks. Curr Opin Struct Biol (2010) 0.97
Network-based approaches in drug discovery and early development. Clin Pharmacol Ther (2013) 0.94
A DIseAse MOdule Detection (DIAMOnD) algorithm derived from a systematic analysis of connectivity patterns of disease proteins in the human interactome. PLoS Comput Biol (2015) 0.93
Structural bioinformatics of the interactome. Annu Rev Biophys (2014) 0.93
Understanding resistance to combination chemotherapy. Drug Resist Updat (2012) 0.88
K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy. Cardiovasc Res (2011) 0.86
From modules to medicine: How modular domains and their associated networks can enable personalized medicine. FEBS Lett (2012) 0.86
DomPep--a general method for predicting modular domain-mediated protein-protein interactions. PLoS One (2011) 0.86
Interspecies protein-protein interaction network construction for characterization of host-pathogen interactions: a Candida albicans-zebrafish interaction study. BMC Syst Biol (2013) 0.85
Systems proteomics for translational network medicine. Circ Cardiovasc Genet (2012) 0.85
Network systems biology for targeted cancer therapies. Chin J Cancer (2011) 0.84
Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (the FinnDiane Study). Cardiovasc Diabetol (2009) 0.83
Network medicine: linking disorders. Hum Genet (2012) 0.83
Identification of specificity determining residues in peptide recognition domains using an information theoretic approach applied to large-scale binding maps. BMC Biol (2011) 0.82
The potential for targeting extracellular LOX proteins in human malignancy. Onco Targets Ther (2013) 0.82
Biomolecular self-defense and futility of high-specificity therapeutic targeting. Gene Regul Syst Bio (2011) 0.81
Cells, shared memory and breaking the PTM code. Mol Syst Biol (2012) 0.81
Computational methods and opportunities for phosphorylation network medicine. Transl Cancer Res (2014) 0.80
Saraca indica bark extract shows in vitro antioxidant, antibreast cancer activity and does not exhibit toxicological effects. Oxid Med Cell Longev (2015) 0.80
Pathway mapping and development of disease-specific biomarkers: protein-based network biomarkers. J Cell Mol Med (2015) 0.80
Ten challenges for systems medicine. Front Genet (2012) 0.79
Optimisation of Downscaled Tandem Affinity Purifications to Identify Core Protein Complexes. J Integr OMICS (2012) 0.79
Diverse array-designed modes of combination therapies in Fangjiomics. Acta Pharmacol Sin (2015) 0.79
Prioritisation and network analysis of Crohn's disease susceptibility genes. PLoS One (2014) 0.78
System level dynamics of post-translational modifications. Curr Opin Biotechnol (2014) 0.77
Dynamic networks in systems medicine. Front Genet (2012) 0.77
Knowledge-Based Analysis for Detecting Key Signaling Events from Time-Series Phosphoproteomics Data. PLoS Comput Biol (2015) 0.77
Protein engineering: a new frontier for biological therapeutics. Curr Drug Metab (2014) 0.76
The 'Tyranny of choices' in the ingestion-controlling network. Obes Facts (2009) 0.76
Ingestion-controlling network: what's language got to do with it? Rev Neurosci (2010) 0.76
RNA-Seq Data: A Complexity Journey. Comput Struct Biotechnol J (2014) 0.76
Mining disease fingerprints from within genetic pathways. AMIA Annu Symp Proc (2012) 0.75
Tetrahydroquinoline-derived macrocyclic toolbox: the discovery of antiangiogenesis agents in zebrafish assay. ACS Med Chem Lett (2013) 0.75
Human Prostate Cancer Hallmarks Map. Sci Rep (2016) 0.75
When Medicine Meets Engineering-Paradigm Shifts in Diagnostics and Therapeutics. Diagnostics (Basel) (2013) 0.75
Disentangling genetic and environmental risk factors for individual diseases from multiplex comorbidity networks. Sci Rep (2016) 0.75
DISCOVERY OF FUNCTIONAL AND DISEASE PATHWAYS BY COMMUNITY DETECTION IN PROTEIN-PROTEIN INTERACTION NETWORKS. Pac Symp Biocomput (2016) 0.75
Systems biology: An emerging strategy for discovering novel pathogenetic mechanisms that promote cardiovascular disease. Glob Cardiol Sci Pract (2016) 0.75
ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res (2003) 6.86
Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol (2009) 5.41
Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC Bioinformatics (2004) 4.44
Linear motif atlas for phosphorylation-dependent signaling. Sci Signal (2008) 3.77
Systematic discovery of new recognition peptides mediating protein interaction networks. PLoS Biol (2005) 3.28
Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell (2009) 3.03
ELM: the status of the 2010 eukaryotic linear motif resource. Nucleic Acids Res (2009) 2.59
Positive selection of tyrosine loss in metazoan evolution. Science (2009) 2.28
Comparative analysis reveals conserved protein phosphorylation networks implicated in multiple diseases. Sci Signal (2009) 2.16
Eukaryotic protein domains as functional units of cellular evolution. Sci Signal (2009) 2.06
WW domains provide a platform for the assembly of multiprotein networks. Mol Cell Biol (2005) 1.97
Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science (2009) 1.91
A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint. PLoS Biol (2010) 1.90
Phosphorylation networks regulating JNK activity in diverse genetic backgrounds. Science (2008) 1.86
DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Mol Cell (2010) 1.78
Computational approaches to identify functional genetic variants in cancer genomes. Nat Methods (2013) 1.64
Normalization of nomenclature for peptide motifs as ligands of modular protein domains. FEBS Lett (2002) 1.46
OpenFreezer: a reagent information management software system. Nat Methods (2011) 1.35
Verification of systems biology research in the age of collaborative competition. Nat Biotechnol (2011) 1.28
Dissecting the interface between signaling and transcriptional regulation in human B cells. Pac Symp Biocomput (2009) 1.28
Navigating cancer network attractors for tumor-specific therapy. Nat Biotechnol (2012) 1.18
In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis. Cell Rep (2013) 1.11
Simplistic pathways or complex networks? Curr Opin Genet Dev (2010) 1.06
Network-based drugs and biomarkers. J Pathol (2010) 1.01
Synthetic modular systems--reverse engineering of signal transduction. FEBS Lett (2005) 0.98
Directional and quantitative phosphorylation networks. Brief Funct Genomic Proteomic (2008) 0.97
Network medicine strikes a blow against breast cancer. Cell (2012) 0.97
Roles of “junk phosphorylation” in modulating biomolecular association of phosphorylated proteins? Cell Cycle (2010) 0.94
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles). Mol Cell Proteomics (2011) 0.94
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles). J Proteome Res (2011) 0.91
Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. FEBS J (2013) 0.91
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles). Proteomics (2011) 0.87
Experimental and computational tools useful for (re)construction of dynamic kinase-substrate networks. Proteomics (2009) 0.84
Cells, shared memory and breaking the PTM code. Mol Syst Biol (2012) 0.81
(R)evolution of complex regulatory systems. Sci Signal (2010) 0.81
Identification of hypoxia-regulated proteins using MALDI-mass spectrometry imaging combined with quantitative proteomics. J Proteome Res (2014) 0.80
Mutational properties of amino acid residues: implications for evolvability of phosphorylatable residues. Philos Trans R Soc Lond B Biol Sci (2012) 0.78
PROTEINCHALLENGE: crowd sourcing in proteomics analysis and software development. J Proteomics (2012) 0.78
BLAST2SRS, a web server for flexible retrieval of related protein sequences in the SWISS-PROT and SPTrEMBL databases. Nucleic Acids Res (2003) 0.76
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles). Proteomics Clin Appl (2011) 0.75
Experimental and computational tools for analysis of signaling networks in primary cells. Curr Protoc Immunol (2014) 0.75